Google Inc. said Monday its health-care research unit agreed to work with European pharmaceutical company Sanofi SA on new ways to monitor and treat diabetes.
The companies declined to say how much they are investing in the partnership.
Sanofi is a leading maker of diabetes medication, as well as many other drugs. Google’s Life Sciences division is working on small, connected medical devices to continuously collect diabetes-related data, as well as software that learns from the information to find new treatments. Diabetes is expected to affect 592 million people world-wide by 2035, according to the International Diabetes Federation.